DWS
CYTK icon

Dynamic Wealth Strategies’s Cytokinetics CYTK Stock Holding History

Dynamic Wealth Strategies’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.79K Hold
68
– – ﹤0.01% 258
2026
Q1 		$4.48K Hold
68
– – ﹤0.01% 257
2025
Q4 		$4.32K Hold
68
– – ﹤0.01% 233
2025
Q3 		$3.74K Hold
68
– – ﹤0.01% 224
2025
Q2 		$2.25K Hold
68
– – ﹤0.01% 223
2025
Q1 		$2.73K Buy
+68
New +$3.13K ﹤0.01% 218
2024
Q4 		– Sell
-68
Closed -$4K – 107
2024
Q3 		$4K Hold
68
– – ﹤0.01% 215
2024
Q2 		$4K Hold
68
– – ﹤0.01% 225
2024
Q1 		$5K Hold
68
– – ﹤0.01% 229
2023
Q4 		$5.68K Buy
+68
New +$2.46K 0.01% 222

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dynamic Wealth Strategies's CYTK Position: Q2 2026 in Review

Dynamic Wealth Strategies held its Cytokinetics (CYTK) position steady in Q2 2026 at 68 shares worth $5.79K. The position accounts for ﹤0.01% of the portfolio, ranked #258.

Dynamic Wealth Strategies first reported a position in CYTK in Q4 2023 and has held it in 10 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Dynamic Wealth Strategies held 68 shares of Cytokinetics worth $5.79K as of Q2 2026.
  • Dynamic Wealth Strategies left its Cytokinetics share count unchanged in Q2 2026.
  • Cytokinetics made up ﹤0.01% of Dynamic Wealth Strategies's portfolio in Q2 2026, its #258 holding.
  • Dynamic Wealth Strategies first reported a position in Cytokinetics in Q4 2023 and has held it in 10 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Dynamic Wealth Strategies's 13F filing for Q2 2026, filed 23 Jul 2026.